Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Aug 14, 2025 8-K
4 Aug 12, 2025
8-K Aug 1, 2025 8-K
8-K Jul 21, 2025 8-K
3 Jul 3, 2025
8-K Jun 26, 2025 8-K
10-Q May 9, 2025 10-Q
8-K May 9, 2025 8-K
ARS May 8, 2025 ARS
DEF 14A Apr 30, 2025 DEF 14A
UPLOAD Apr 30, 2025
S-3 Apr 28, 2025 FORM S-3
8-K Apr 23, 2025 8-K
8-K Mar 17, 2025 8-K
424B5 Mar 17, 2025 424B5
10-K Mar 17, 2025 10-K
8-K Mar 17, 2025 8-K
8-K Dec 31, 2024 8-K
8-K Dec 23, 2024 8-K
10-Q Nov 14, 2024 10-Q
8-K Nov 14, 2024 8-K
4/A Nov 5, 2024
SC 13G/A Oct 25, 2024
8-K Oct 25, 2024 8-K
4 Sep 24, 2024
← Newer Page 3 of 38 · 935 filings Older →